# Bupivacaine Epiphora Trial

> **NCT03266081** · PHASE2 · WITHDRAWN · sponsor: **McMaster University**

## Conditions studied

- Epiphora
- Ptosis

## Interventions

- **DRUG:** 0.75% bupivacaine

## Key facts

- **NCT ID:** NCT03266081
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-04
- **Primary completion:** 2022-08-23
- **Final completion:** 2022-08-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266081, "Bupivacaine Epiphora Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03266081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*